PENTACEF Drug Patent Profile
✉ Email this page to a colleague
When do Pentacef patents expire, and when can generic versions of Pentacef launch?
Pentacef is a drug marketed by Glaxosmithkline and is included in three NDAs.
The generic ingredient in PENTACEF is ceftazidime. There are seventeen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pentacef
A generic version of PENTACEF was approved as ceftazidime by ACS DOBFAR on November 20th, 1985.
Summary for PENTACEF
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 42 |
| Patent Applications: | 7,813 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PENTACEF at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PENTACEF
US Patents and Regulatory Information for PENTACEF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | PENTACEF | ceftazidime | INJECTABLE;INJECTION | 063322-001 | Nov 7, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Glaxosmithkline | PENTACEF | ceftazidime | INJECTABLE;INJECTION | 064006-002 | Mar 31, 1992 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Glaxosmithkline | PENTACEF | ceftazidime | INJECTABLE;INJECTION | 064006-001 | Mar 31, 1992 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Glaxosmithkline | PENTACEF | ceftazidime | INJECTABLE;INJECTION | 063322-002 | Nov 7, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Glaxosmithkline | PENTACEF | ceftazidime | INJECTABLE;INJECTION | 064008-002 | Mar 31, 1992 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
